SCHEMBL21945899

SCHEMBL21945899

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc(-c4ccc5c(c4)C(c4ccccc4)c4ccccc4-5)cc3)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.37
LMNA P02545 3/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
MEN1 O00255 2/20 0.37
HTT P42858 2/20 0.37
KMT2A Q03164 2/20 0.37
APAF1 O14727 1/20 0.37
NPC1 O15118 1/20 0.37
THRB P10828 1/20 0.37
XBP1 P17861 1/20 0.37
PTBP1 P26599 1/20 0.37
RAB9A P51151 1/20 0.37
GALK1 P51570 1/20 0.37
BLM P54132 1/20 0.37
SMAD3 P84022 1/20 0.37
ATM Q13315 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
ALDH1A1 P00352 3/20 0.34
CYP1A2 P05177 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19008928 0.94 MAPT (0.34) MAPTLMNAL3MBTL1MEN1HTT
SCHEMBL20621541 0.91 EDNRB (0.40) MAPTLMNAL3MBTL1MEN1HTT
SCHEMBL18070187 0.91 EDNRB (0.40) MAPTLMNAL3MBTL1MEN1HTT
SCHEMBL24350284 0.91 MAPT (0.38) MAPTLMNAL3MBTL1MEN1HTT
SCHEMBL21969031 0.91 EDNRB (0.40) MAPTLMNAL3MBTL1MEN1HTT
SCHEMBL13805299 0.90 EDNRB (0.39) MAPTLMNAL3MBTL1MEN1HTT
SCHEMBL24416591 0.90 MAPT (0.37) MAPTLMNAL3MBTL1MEN1HTT
SCHEMBL24416592 0.90 MAPT (0.37) MAPTLMNAL3MBTL1MEN1HTT
SCHEMBL17852151 0.89 ALDH1A1 (0.39) MAPTLMNAL3MBTL1MEN1KMT2A
SCHEMBL15801645 0.89 ALDH1A1 (0.39) MAPTLMNAL3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200127211-A1 PHENYL BIPHENYLPYRIMIDINE COMPOUND AND AN ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2020-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200127211-A1 PHENYL BIPHENYLPYRIMIDINE COMPOUND AND AN ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DPYD, NUDT1, PNP MAPT 4095/4885LMNA 3569/4885L3MBTL1 578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.